Hemolysis-associated phosphatidylserine exposure promotes polyclonal plasmablast differentiation

Area of Science:

• Immunology
• Infectious Diseases
• Hematology

Background:

• Antimalarial antibodies are crucial for clearing Plasmodium-infected red blood cells (RBCs).
• Rapid plasmablast expansion in malaria can suppress durable humoral immunity.
• Understanding plasmablast formation mechanisms is key to improving malaria control.

Purpose of the Study:

• To elucidate the mechanisms driving plasmablast formation during Plasmodium infection.
• To investigate the role of hemolysis and phosphatidylserine in plasmablast development.
• To explore therapeutic strategies targeting plasmablast expansion for improved antimalarial immunity.

Main Methods:

• Studied Plasmodium-infected mouse models.
• Induced hemolysis and administered RBC membrane ghosts.
• Utilized phosphatidylserine receptor Axl blockade.
• Assessed plasmablast populations and parasite burden in vivo.

Main Results:

• Plasmablast formation is linked to hemolysis-induced phosphatidylserine exposure on RBCs and inflammation.
• Virus and Trypanosoma infections also induce plasmablast responses via hemolysis and inflammation.
• Blocking phosphatidylserine limits plasmablast expansion and reduces Plasmodium parasite burden.
• RBC membrane ghosts promote plasmablast differentiation.

Conclusions:

• Modulating B cell activation and phosphatidylserine exposure can enhance immune responses against Plasmodium.
• These strategies may also benefit other infectious diseases associated with anemia.
• Targeting phosphatidylserine offers a potential therapeutic avenue for improving malaria immunity.